Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2005
11/03/2005CA2835840A1 Beneficial effects of increasing local blood flow
11/03/2005CA2805603A1 Bioresorbable stent with beneficial agent reservoirs
11/03/2005CA2798552A1 Poly(lactide-co-glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar
11/03/2005CA2564353A1 Galantamine salts, method of producing it and nasal composition thereof
11/03/2005CA2564180A1 Pharmaceutical preparation containing bacterial cell wall skeleton component
11/03/2005CA2564019A1 Lozenge for delivery of dextromethorphan
11/03/2005CA2564000A1 Pharmaceutical compositions for glucocorticoid replacement therapy
11/03/2005CA2563861A1 Cholinesterase inhibitors in liposomes and their preparation and use
11/03/2005CA2563744A1 Composition comprising a diuretic and/or cardiac glycoside for the treatment of dna viral infections of the eye
11/03/2005CA2563680A1 Seamless capsule containing water-soluble active substance
11/03/2005CA2563678A1 Beneficial effects of increasing local blood flow
11/03/2005CA2563670A1 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
11/03/2005CA2563665A1 Method of stabilizing disordered cefovecin sodium salt
11/03/2005CA2563556A1 Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
11/03/2005CA2562731A1 Apparatus and method for transdermal delivery of fentanyl-based agents
11/03/2005CA2561553A1 Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
11/03/2005CA2560667A1 Chitosan embedded or encapsulated capsule
11/02/2005EP1591505A1 Medical non-crosslinked pressure-sensitive adhesive composition, medical adhesive sheet employing the same and, process for producing medical non-crosslinked pressure-sensitive adhesive composition
11/02/2005EP1591467A1 Conjugate between a polyethylene glycol having a terminal alkanal group and a human growth hormone
11/02/2005EP1591451A1 Peptide conjugate
11/02/2005EP1591450A1 Conjugate for retention in blood and cancer tissue-specific drug delivery
11/02/2005EP1591447A1 Phospholipid derivatives and process for the production there
11/02/2005EP1591135A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
11/02/2005EP1591125A1 Pharmaceutical composition comprising extracts of lichens and hypericum
11/02/2005EP1591124A1 Galenic preparation for anal administration in the treatment of haemorrhoids
11/02/2005EP1591121A1 Steroid hormone products comprising a stabilizing agent in non-crystalline form
11/02/2005EP1591111A1 Thin aqueous cataplasm material
11/02/2005EP1591110A1 Percutaneous absorption preparation for treating ophthalmic disease, use thereof and method for migration of ophthalmic remedy into topical tissue in eye
11/02/2005EP1591109A1 Formulation comprising histone deacetylase inhibitor exhibiting biphasic release
11/02/2005EP1591108A2 Solution formulations of sirolimus and its analogs for CAD treatment
11/02/2005EP1591107A1 Process for the selective increase of a release rate of an active material from a pharmaceutical composition
11/02/2005EP1591106A1 Film preparation and process for preparing the same
11/02/2005EP1591020A1 Compositions containing coenzyme q10
11/02/2005EP1590613A2 Lyophilization method and apparatus for producing particles
11/02/2005EP1590388A2 Block copolymers
11/02/2005EP1590144A1 Method of preparing biologically active formulations
11/02/2005EP1590077A2 Microencapsulation systems and applications of same
11/02/2005EP1590041A2 Treatment of periodontal disease with photosensitizers
11/02/2005EP1590033A2 Drug delivery device having coated microprojections incorporating vasoconstrictors
11/02/2005EP1590009A1 Coating composition for skin-contacting surface of elastomeric articles and articles containing the same
11/02/2005EP1590006A2 Ultrasound contrast agents and process for the preparation thereof
11/02/2005EP1590004A2 Improved thickened beverages for dysphagia
11/02/2005EP1589999A2 Polyvinylethers for delivery of polynucleotides to mammalian cells
11/02/2005EP1589992A2 Method for treating elevated intraocular pressure, including glaucoma
11/02/2005EP1589987A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing
11/02/2005EP1589982A1 Packs on the base of chalk and paraffin
11/02/2005EP1589978A2 Delivery system for functional compounds
11/02/2005EP1589977A1 Topical ointment for vesicating chemical warfare agents
11/02/2005EP1589973A1 Formulation and methods for the treatment of thrombocythemia
11/02/2005EP1589971A1 Ophthalmic compositions containing loratadine
11/02/2005EP1589957A1 Pharmaceutical compositions and process of production thereof
11/02/2005EP1589956A2 Transdermal granisetron
11/02/2005EP1589955A2 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof
11/02/2005EP1589954A2 Composition comprising a mixture of active principles, and method of preparation
11/02/2005EP1589953A1 Pharmaceutical compositions comprising an active agent and chitosan for sustained drug release or mucoadhesion
11/02/2005EP1589952A2 Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
11/02/2005EP1589951A2 Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
11/02/2005EP1589950A1 Methods for making pharmaceutical dosage forms containing active cushioning components
11/02/2005EP1589949A1 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants
11/02/2005EP1589948A1 Drug particles obtained by freezing onto a cold surface
11/02/2005EP1589947A2 Pharmaceutical formulation with an insoluble active agent for pulmonary administration
11/02/2005EP1589946A2 Solution for nostril wash
11/02/2005EP1589945A1 Topical pharmaceutical and/or cosmetic dispense systems
11/02/2005EP1589944A2 Pharmaceutical preparations and a method for their production
11/02/2005EP1589943A2 Methods of treating lung diseases
11/02/2005EP1589917A2 Methods of administering a dermatological agent to a subject
11/02/2005EP1589901A2 Intracutaneous injection
11/02/2005EP1516624A9 Method of producing calcium gluconolactate, compositions, processes and uses of same
11/02/2005EP1482796A4 Stable compositions comprising tezacitabine
11/02/2005EP1389910A4 Intraoral delivery of nicotine for smoking cessation
11/02/2005EP1356825B1 Process for producing aqueous cellulose derivative dispersion
11/02/2005EP1307227B1 Pharmaceutical compositions
11/02/2005EP1307181B1 Novel compositions of minoxidil
11/02/2005EP1296691B1 Use of cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infections
11/02/2005EP1257254B1 Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
11/02/2005EP1251780A4 LUMINESCENT i IN VIVO /i GLUCOSE MEASUREMENT
11/02/2005EP1212039B1 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent
11/02/2005EP1200320B1 Valve with a two-component seal
11/02/2005EP1200042B1 Emulsifier-free finely dispersed systems of the oil-in-water type
11/02/2005EP1194133B1 Multilayered film containing an active substance and made of cross-linked hydrophilic polymers
11/02/2005EP1169244B1 Metering valve
11/02/2005EP1117443B1 Peptide-based carrier devices for stellate cells
11/02/2005EP1097722B1 Excipient
11/02/2005EP1061873B1 Use of glyceraldehyde as corneal hardening agents
11/02/2005EP1059916B1 Extended release dosage form
11/02/2005EP1011767B1 Device for administering insulin in controlled dosages by controlling total inhaled volume
11/02/2005EP1009414B1 Novel pharmaceutical composition comprising clindamycin and clotrimazol for the treatment of vaginal infections
11/02/2005CN1692157A DNA nanocage by self-organization of DNA and process for producing the same, and DNA nanotube and molecule carrier using the same
11/02/2005CN1691969A Microneedle devices and microneedle delivery apparatus
11/02/2005CN1691965A Pharmaceutical composition for controlled release and manufacturing method thereof
11/02/2005CN1691962A Improvements of bacterin or related to bacterin
11/02/2005CN1691942A Dry syrup preparation of procaterol comprising ascorbinic acid and citric acid
11/02/2005CN1691938A Transdermal vaccine delivery device having coated microprotrusions
11/02/2005CN1691937A Coated conditioners for use in foods and pharmaceuticals
11/02/2005CN1691936A Combined immediate release and extended release analgesic composition
11/02/2005CN1691935A Ascorbic acid salt suspensions and use thereof as antioxidants
11/02/2005CN1689651A Medical non-crosslinked pressure-sensitive adhesive composition, process for producing medical non-crosslinked pressure-sensitive adhesive composition and medical adhesive sheet
11/02/2005CN1689649A Oral cavity quick dissolving preparation and production method thereof
11/02/2005CN1689576A Magnetic slow release 5-aminosalicylic acid with intercalate structure and its preparation method
11/02/2005CN1689557A Method for preparing hollow minisphere for lung administration
1 ... 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 ... 2991